PL

Pengpeng Li

Vice President at Lilly Asia Ventures

Boston, Massachusetts

Overview

Work Experience

  • Vice President

    2024 - Current

  • Senior Investment Manager

    2022 - 2024

  • Associate

    2021 - 2022

    Dedicated to creating value in early-stage life science companies through company building and investing.

  • Analyst

    2019 - 2020

  • Fellow

    2019 - 2019

  • Strategy and Operations

    2019 - 2022

  • Postdoctoral Research Fellow

    2016 - 2019

    Developed novel method to profile cell lineage and cell type in single cells, and applied it to studying human brain development

  • Business Development Fellow

    2017 - 2019

    Focused on technical and commercial assessment of early-stage life science, biomedical and healthcare techonologies

  • Stanford Ignite

    2016 - 2016

    Global Innovation Program, Entrepreneurship & Innovation

  • PhD Student

    2010 - 2016

    Studied the mechanisms of neurodevelopment and how it influences the establishment of neural circuits and function of nervous system.

  • Undergraduate Research Fellow

    2006 - 2010

    Studied the molecular mechanisms of ethylene signaling and how it interacts with other plant hormone signaling pathways and influences plant development.

  • Undergraduate Intern

    2008 - 2008

    Involved in developing an anti-cancer small molecule drug. Tested and improved its performance using in vitro assays.

Relevant Websites